Cargando…

Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials

Detalles Bibliográficos
Autores principales:	Ternès, Nils, Rotolo, Federico, Heinze, Georg, Michiels, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659260/ http://dx.doi.org/10.1186/1745-6215-16-S2-O86

Ejemplares similares

Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
por: Ternès, Nils, et al.
Publicado: (2016)

Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2017)

Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models
por: Belhechmi, Shaima, et al.
Publicado: (2020)

Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice
por: Michiels, S., et al.
Publicado: (2016)

Testing the treatment effect on competing causes of death in oncology clinical trials
por: Rotolo, Federico, et al.
Publicado: (2014)

Irisin and the therapeutic benefits of exercise
por: Spiegelman, Bruce M, et al.
Publicado: (2012)

The bioenergetic signature of cancer
por: Cuezva, José M
Publicado: (2010)

Three-dimensional mammography
por: Yaffe, MJ
Publicado: (2008)

An alternative trial-level measure for evaluating failure-time surrogate endpoints based on prediction error
por: Belhechmi, Shaima, et al.
Publicado: (2019)

Randomized controlled trials: who fails run-in?
por: Rees, Judy R, et al.
Publicado: (2015)

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
por: Ahmed, Nabil, et al.
Publicado: (2015)

A novel measure of treatment benefit for an ordinal scale: a case study of the IST-1 and the IST-3 stroke trials
por: Thompson, Douglas, et al.
Publicado: (2013)

Favoring the hierarchical constraint in penalized survival models for randomized trials in precision medicine
por: Belhechmi, Shaima, et al.
Publicado: (2023)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Identification of Blau Syndrome disease signatures
por: Foley, KP, et al.
Publicado: (2011)

The risks and benefits of RTPA in acute ischemic stroke for patients at high risk of intracranial haemorrhage and poor functional outcome: a secondary analysis of the IST-3 trial and systematic review of prediction models
por: Thompson, Douglas, et al.
Publicado: (2013)

Benefits of early aneurysm surgery: Southern Iran experience
por: Rahmanian, Abdolkarim, et al.
Publicado: (2012)

Risk prediction in stable coronary artery disease using quantified myocardial ischemia and necrosis by cardiac magnetic resonance imaging - a prospective long-term follow-up trial
por: Buckert, Dominik, et al.
Publicado: (2016)

Finding mechanisms from metabolic signatures of disease
por: Newgard, Christopher B
Publicado: (2012)

The epigenetic signature of chronic pain in the mouse brain
por: Tajerian, Maral, et al.
Publicado: (2014)

Benefits of non-medical prescribing within an NHS podiatry service
por: Popadiuk, Susan, et al.
Publicado: (2010)

Controversial Issue Session: Brace treatment in infantile scoliosis: benefits
por: Claude de Mauroy, Jean
Publicado: (2012)

Benefits of PDE5 inhibition in patients with diastolic heart failure
por: Guazzi, Marco
Publicado: (2011)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Developed-developing country partnerships: benefits from South to North?
por: Syed, SB, et al.
Publicado: (2011)

Benefits of using heated egg (HE) in the management of egg allergy
por: Claver, A, et al.
Publicado: (2013)

Health benefits from moderate drinking: a critical review
por: Andreasson, Sven, et al.
Publicado: (2015)

Investigating strategies to improve attendance at screening visits in a randomized trial
por: Chen, Fang, et al.
Publicado: (2011)

Sensitivity analyses for trials with missing data, assuming missing not at random mechanisms
por: Leurent, Baptiste, et al.
Publicado: (2013)

Three-dimensional microscopy of the human bronchial mucosa
por: Suter, Melissa, et al.
Publicado: (2010)

Carbohydrate restriction uniquely benefits metabolic syndrome and saturated fat metabolism
por: Volek, Jeff S
Publicado: (2012)

Enriching the evidence base: moving towards full societal costs and benefits
por: Brouwer, Werner
Publicado: (2014)

Benefits from using recycling red blood cells in cardiovascular surgery
por: Almeida, R, et al.
Publicado: (2013)

Using linear increment models for the imputation of missing composite outcomes in randomized trials
por: O’Keeffe, Aidan G, et al.
Publicado: (2011)

High-speed three-dimensional imaging of the pulmonary alveoli
por: Namati, Eman, et al.
Publicado: (2010)

Three-dimensional reconstructions of Lenke 1A Curves
por: Deceunininck, Julie, et al.
Publicado: (2013)

Three-dimensional reconstructions of Lenke 5C Curves
por: Deceuninck, Julie, et al.
Publicado: (2013)

Molecular signatures of rheumatoid arthritis characterized by transcriptome and proteome analysis
por: Glocker, MO, et al.
Publicado: (2005)

Improved brace design combining CAD/CAM and finite element simulation for the conservative treatment of adolescent idiopathic scoliosis (AIS): preliminary results of a randomized control trial
por: Aubin, Carl-Éric, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n2k4cfqkou31e27fegocf6bvnl